Occurrence and impact of upper airways symptoms in never smoker COPD patients

C. Tarke (Hyderabad, India)

Source: International Congress 2017 – Highlights on clinical problems in COPD
Session: Highlights on clinical problems in COPD
Session type: Thematic Poster
Number: 3637
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Tarke (Hyderabad, India). Occurrence and impact of upper airways symptoms in never smoker COPD patients. 3637

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
What is the origin of dyspnoea in smokers without airway disease?
Source: Eur Respir J 2016; 48: 604-607
Year: 2016


The prevelance of chronic nasal symptoms in COPD patients
Source: Eur Respir J 2002; 20: Suppl. 38, 264s
Year: 2002

The impact of smoking cessation on respiratory symptoms in patients with COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 391s
Year: 2005

Occurrence and impact of bronchiectasis in patients with COPD
Source: International Congress 2017 – Highlights on clinical problems in COPD
Year: 2017


Status of upper airways in exacerbation of COPD
Source: Annual Congress 2012 - Distinguishing phenotypes and dealing with comorbidities in primary care
Year: 2012


Chronic airflow limitation and respiratory symptoms among smokers and never smokers
Source: International Congress 2019 – COPD: epidemiology and spirometry
Year: 2019

United airway: upper and lower respiratory symptoms of COPD patients
Source: International Congress 2019 – Advances in clinical management of COPD
Year: 2019

Individual risks of developing chronic bronchitis and respiratory symptoms  in smokers
Source: Virtual Congress 2021 – Health effects of tobacco and medical professionals
Year: 2021


Clinically concomitant involvement of upper airways in patients with bronchial asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 510s
Year: 2004

Does dyspnea perception match the severity of airway obstruction in COPD outpatients?
Source: Eur Respir J 2004; 24: Suppl. 48, 57s
Year: 2004

Drivers of respiratory symptoms in COPD patients
Source: International Congress 2018 – Patient-reported outcomes and scores in COPD
Year: 2018


The bronchitic phenotype is associated with frequent exacerbations in COPD irrespective of chronic bacterial airway infection
Source: Annual Congress 2013 –Guidelines and exacerbations
Year: 2013

Interpreting thresholds for a clinically significant change in health status in asthma and COPD
Source: Eur Respir J 2002; 19: 398-404
Year: 2002



What are the consequences of chronic cough and expectoration for health status among patients with COPD?
Source: Eur Respir J 2003; 22: Suppl. 45, 577s
Year: 2003

Physiological impairments and exacerbation risk in COPD patients with less symptom and no frequent exacerbation history.
Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD
Year: 2021


Assessment of nicotine dependence in healthy people and patients with chronic pulmonary obstructive disease or bronchial asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 134s
Year: 2002

Predictors of exercise-induced airways obstruction in patients with mild asthma.
Source: Virtual Congress 2020 – Exploring exercise responses in respiratory diseases
Year: 2020


frequent exacerbations of COPD are associated with severity of airflow limitation and chronic cough, sputum production.
Source: International Congress 2019 – Airway disease-associated exacerbations
Year: 2019


The effect of smoking on exacerbation risk in eosinophilic patients with COPD
Source: Eur Respir J, 50 (6) 1702086; 10.1183/13993003.02086-2017
Year: 2017



The effect of smoking on exacerbation risk in eosinophilic patients with COPD
Source: Eur Respir J, 50 (6) 1701820; 10.1183/13993003.01820-2017
Year: 2017